EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.

By P. Cornford, J. Bellmunt, Michel Bolla, E. Briers, M. De Santis, T. Gross, A. Henry, Steven Joniau, T. Lam, M. Mason and 5 more. European Urology, 2017

1,488 citations recorded by the source corpus.

Subfields: Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/1a4b793d69d2b702fa9927e298c7fd6c1af565e4

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. N. Mottet
2. Thomas Wiegel

In Pulmonary and Respiratory Medicine

1. N. Mottet
2. Thomas Wiegel

Citations in the corpus

• EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer. (2020, background): “A prior summary of the European Association of Urology (EAU) guidelines on prostate cancer (PCa) was published in 2017 [1].”
• Abiraterone plus Prednisone in Metastatic, Castration‐Sensitive Prostate Cancer (2017, neutral): “Anemia 54 (9) 12 (2) 3 (1) 85 (14) 26 (4) 1 (<1)”